Retinal Biologics Global Market Report 2023: Innovations Key to Future Advances - Long-term Forecasts to 2028 and 2033
January 25, 2024 09:33 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Retinal Biologics Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. Profound analytics indicate that the...
Non-Infectious Macular Edema Treatment Market Set to Experience Exponential Growth by 2031 with Prominent Demand for Corticosteroids in North America and Europe
January 25, 2024 06:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Non-infectious Macular Edema Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...
Global Retinal Vein Occlusion Treatment Market Poised for Remarkable Growth, Expected to Reach $4.18 Billion by 2030
October 30, 2023 11:13 ET
|
Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- The "Retinal Vein Occlusion Treatment Market Size, Share & Trends Analysis Report By End-user (Retail Pharmacy, Hospital & Clinics), By Disease Type...
Retinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsight
October 23, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Retinal Vein Occlusion Market to Exhibit Considerable Growth at a CAGR of ~6% During the Study Period (2019–2032) | DelveInsight The increasing...
Retinal Vein Occlusion Treatment Market to reach US$ 2.3 billion in 2023 -end, expected to grow at a 5.9% CAGR until 2033: Future Market Insights, Inc.
March 21, 2023 12:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 21, 2023 (GLOBE NEWSWIRE) -- The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a...
Retinal Vein Occlusion: Global Outlook and Current and Emerging Treatment Practices 2021
June 30, 2021 06:23 ET
|
Research and Markets
Dublin, June 30, 2021 (GLOBE NEWSWIRE) -- The "Retinal Vein Occlusion - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This...
Clearside Biomedical, Inc. to Present at J.P. Morgan Healthcare Conference
January 05, 2017 07:30 ET
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye...